Cite

HARVARD Citation

    Wheeler, M. et al. (2019). Idarucizumab for dabigatran reversal: the first 6 months in a tertiary centre. Internal medicine journal. 49 (10), pp. 1316-1320. [Online]. 
  
Back to record